A group of researchers from Thailand, the U.K. and elsewhere have developed a blood test that can identify people who have drug-resistant malaria.
Here's why: The top 5 diagnostics-related venture capital deals in the 2014 second quarter are much more robust than those from the previous quarter, reflecting a larger med tech trend that produced a healthy hike in both deal value and volume versus Q1.
We all know the life sciences industry produces plenty of hype about new diagnostic advances, cutting-edge treatments and lifesaving surgeries. Many are profoundly amazing and life-changing inventions that have saved countless lives. But the truth is that much of patient diagnosis and care remains guesswork, trial, error and hope. Read more >>
POPULAR COMMENT THREADS
LabCorp is stepping up with a new noninvasive prenatal genetic screening test, adding some large-company muscle to a market already packed with a number of rival assays.
Cancer Genetics isn't making money yet. But the New Jersey developer of DNA-based cancer diagnostics closed out its 2014 second quarter with smaller losses, some strategic acquisitions and a biomarker development partnership with AstraZeneca.
Aspergillus is a mold that infects the respiratory system and can lead to serious illness or death in patients with weakened immune systems. Researchers believe they've found the ideal combination of tests for early, effective diagnosis.
Biocept recently released its 2014 second-quarter earnings as well as a corresponding update on the company's progress. Its results, which include much higher losses, highlight the molecular diagnostics player's aggressive strategy to achieve commercial success, and how far away it is from actually getting there.
Germany's Protagen said it is rolling out its first diagnostic test kit for systemic sclerosis, a rheumatic disease in which autoimmune-induced inflammation, fibrosis and blood vessel disorders can harm a patient's organs and eventually cause death.
Seventh Sense Biosystems has been quiet these last several months. But now the maker of painless blood collection and diagnostic tech is making some noise, having scored a healthy new round of venture financing.
From Our Sister Sites
Amid a sea of companies creating mobile medical devices, a Philadelphia startup hopes to set itself apart and deliver an innovative product that provides quick, at-home lab diagnostics on a smartphone.
The PharmaJet injector delivers the vaccine by means of a narrow, precise fluid stream that penetrates the skin in about one-tenth of a second.